Literature DB >> 19081479

An easy-to-use solution for clinical audit in colorectal cancer surgery.

Giampaolo Ugolini1, Giancarlo Rosati, Isacco Montroni, Simone Zanotti, Alessio Manaresi, Luca Giampaolo, Mario Taffurelli, Victor Pricolo.   

Abstract

BACKGROUND: Clinical audit has been increasingly required for the accreditation process in every modern healthcare system. Data collection and analysis are excessively time-consuming in everyday practice. The primary aim of our study was to evaluate the effectiveness of an innovative database to assist surgeons in monitoring clinical practice outcomes in colorectal cancer surgery. The second purpose was to compare observed mortality rates to 3 risk-predicting operative scoring systems.
METHODS: Data were evaluated from 208 consecutive patients undergoing elective and emergency surgery for colorectal cancer over a 2-year period (2003-2004). A new database was developed with specific queries to compare the observed and the expected mortality rates according to 3 scoring systems: the Portsmouth-Physiological and Operative Severity Score for enUmeration of Mortality and morbidity (P-POSSUM), the ColoRectal-Physiological and Operative Severity Score for enUmeration of Mortality and morbidity (CR-POSSUM), and the Association of ColoProctology or Great Britain & Ireland (ACPGBI) score. Results were discussed at regular intervals. Surgeons' satisfaction with each system was evaluated with a questionnaire.
RESULTS: The observed mortality rate was 6.25%, which was significantly lower than the values predicted by CR-POSSUM and ACPGBI colorectal scores (9.14% and 19.42%, respectively; P < .05). P-POSSUM was the most accurate predictor of mortality, with a value of 7.93%. A total of 80% of the surgical staff considered this type of surgical audit activity as clinically useful.
CONCLUSION: The study confirms the usefulness of a dedicated database in a surgical audit activity. The ACPGBI colorectal score largely overestimated 30-day mortality in our experience.

Entities:  

Mesh:

Year:  2008        PMID: 19081479     DOI: 10.1016/j.surg.2008.07.012

Source DB:  PubMed          Journal:  Surgery        ISSN: 0039-6060            Impact factor:   3.982


  7 in total

1.  Predicting post-operative mortality in patients undergoing colorectal surgery using P-POSSUM and CR-POSSUM scores: a prospective study.

Authors:  Edmund Leung; Ali M Ferjani; Nigel Stellard; Ling S Wong
Journal:  Int J Colorectal Dis       Date:  2009-07-30       Impact factor: 2.571

2.  Complete mesocolic excision--a marker of surgical quality?

Authors:  Aisling M Hogan; Des C Winter
Journal:  J Gastrointest Surg       Date:  2009-08-05       Impact factor: 3.452

Review 3.  A systematic review of POSSUM and its related models as predictors of post-operative mortality and morbidity in patients undergoing surgery for colorectal cancer.

Authors:  Colin Hewitt Richards; Fiona E Leitch; Paul G Horgan; Donald C McMillan
Journal:  J Gastrointest Surg       Date:  2010-09-08       Impact factor: 3.452

4.  Australasian ACPGBI risk prediction model for 30-day mortality after colorectal cancer surgery.

Authors:  S Wilkins; K Oliva; E Chowdhury; B Ruggiero; A Bennett; E J Andrews; O Dent; P Chapuis; C Platell; C M Reid; P J McMurrick
Journal:  BJS Open       Date:  2020-09-28

5.  Remnant uptake as a postoperative oncologic quality indicator.

Authors:  David F Schneider; Kristin A Ojomo; Herbert Chen; Rebecca S Sippel
Journal:  Thyroid       Date:  2013-07-17       Impact factor: 6.568

6.  Predictive value of POSSUM and ACPGBI scoring in mortality and morbidity of colorectal resection: a case-control study.

Authors:  Pascal H E Teeuwen; A J A Bremers; J M M Groenewoud; C J H M van Laarhoven; R P Bleichrodt
Journal:  J Gastrointest Surg       Date:  2010-10-09       Impact factor: 3.452

7.  Potential hospital cost-savings attributed to improvements in outcomes for colorectal cancer surgery following self-audit.

Authors:  Louisa G Gordon; Andreas Obermair
Journal:  BMC Surg       Date:  2010-01-27       Impact factor: 2.102

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.